The Investor, the Strategist, the Skeptic, the Data Scientist, and the Futurist debate every deal and portfolio decision — so your conviction is earned, not inherited.
The Skeptic and Devil's Advocate argue against your thesis with the same rigor you'd hope an LP would. Catch the hole before you write the check.
Position sizing, sector concentration, follow-on strategy — modeled with The Investor and The Analyst.
Team, market, product, terms — each dimension debated separately, then synthesized into a conviction call.
Hold vs. sell vs. average down — argued with second-order tax and signaling effects framed explicitly.
Real questions. Multiple expert perspectives. Every time.
“I have conviction on this deal. Walk me through the strongest reasons I'm wrong.”
“Two follow-on opportunities at different stages. Concentrate or diversify?”
“A portfolio company has missed every milestone. Double down, hold, or write it off?”
“Should I take pro-rata in the next round or sell into secondary at current valuation?”
“How do I size my position when the founder is exceptional but the market is unclear?”
Each expert thinks independently — they won’t just agree with each other.
The Investor
Thinks like a board, an LP, and a downstream acquirer at once.
The Strategist
Maps competitive dynamics and strategic options across multi-year horizons.
The Skeptic
Questions every premise. Finds blind spots others miss.
The Data Scientist
Pulls the analysis behind every confident claim.
The Futurist
Pulls the 5- and 10-year scenarios most teams forget to model.
A synthesized recommendation from your team of experts — not just opinions, but structured analysis.
Moderate Agreement
Key Recommendations
Synthesized Recommendation
Take 50% of pro-rata, sell 25% into secondary. Preserves upside if the next round prices well; locks in a partial return that funds three new positions; and signals continued conviction without full concentration.
Full analysis continues with detailed reasoning, trade-offs, and next steps...
Watch Out For
Expert Opinions
“Returns come from the deals you didn't do as much as the ones you did. The boardroom is the cheapest way to test conviction before the IC vote — or before the angel check clears.”
You can't always get a partner to argue against your deal. The Boardroom can — at any hour, with structured opposition.
The Boardroom remembers your thesis, prior bets, and stated principles. Builds a defensible decision history for LP letters and retrospectives.
Team, market, product, terms, signaling — each dimension debated separately rather than collapsed into a single overall vibe.
Some deal evaluations can't happen in a fund Slack or in front of an associate. The Boardroom is private to your account.
The questions people ask before they sign up.
Both, with different lineups. Angels typically run The Investor, The Skeptic, The Strategist, and The CFO. Institutional investors add The Data Scientist for portfolio-level analysis. Family offices and PE often add The Lawyer for deal-term review.
No — partner debate has the value of relationship continuity and shared accountability. SynthBoard is the pre-partnership-meeting analysis tool. Many investors run sessions before Monday meetings to arrive with structured opposition already considered.
Sessions are private. For maximally sensitive deals, use anonymized context (sector + stage + team profile without names). The structural recommendation will still apply. Always validate against your fund's AI-tool policies.
Indirectly — the decision-journal aspect produces a documented rationale for each deal you can reference in LP letters and quarterly reports. The Boardroom doesn't write LP comms directly, but the synthesized memos make the work faster.
Synths reason from general patterns and current market context, not real-time data. For specific market-comp analysis (recent transaction multiples, sector heat), pair with your data subscriptions. The Boardroom is for the conviction layer, not the data-gathering layer.
No — it argues each deal on merit. The Skeptic surfaces objections, The Investor often counters them, and the synthesis lands a conviction read. Many investors report it surfaces conviction on deals they were leaning away from, not just objections to deals they were leaning into.
Adjacent decisions, audiences, and methods inside SynthBoard.
Specifically for venture-stage investors.
ExploreFor private angels and syndicate leads.
ExploreCapital deployment framework.
ExplorePre-mortem an investment decision.
ExploreIndividual investor workflow.
ExploreReal investor sessions.
Explore250 bonus credits at signup. 150 free every month. No card required.